Hope for EoE patients: drug may allow return of favorite foods
NCT ID NCT05247866
Summary
This study tested if a medication called dupilumab could help children and young adults with eosinophilic esophagitis (EoE) safely reintroduce foods that normally trigger their condition. Participants aged 6 to 25 took dupilumab for 12 weeks to control their EoE. If their condition improved, they then tried slowly adding back common trigger foods like milk, egg, wheat, or soy while doctors monitored them with endoscopies over 48 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EOSINOPHILIC ESOPHAGITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.